Back
Calidi Biotherapeutics Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
52
CLDI
Calidi Biotherapeutics
Last Price:
2.16
Seasonality Move:
-22.83%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.- The current trend is moderately bullish and CLDI is experiencing slight buying pressure.
Calidi Biotherapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.36 | Sell |
| 20-day SMA: | 1.8 | Buy |
| 50-day SMA: | 1.38 | Buy |
| 200-day SMA: | 2.71 | Sell |
| 8-day EMA: | 2.18 | Sell |
| 20-day EMA: | 1.9 | Buy |
| 50-day EMA: | 1.6 | Buy |
| 200-day EMA: | 8.19 | Sell |
Calidi Biotherapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.29 | Buy |
| Relative Strength Index (14 RSI): | 56.69 | Buy |
| Chaikin Money Flow: | 734857 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.04 - 2.24) | Buy |
| Bollinger Bands (100): | (1.03 - 1.83) | Buy |
Calidi Biotherapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Calidi Biotherapeutics Stock
Is Calidi Biotherapeutics Stock a Buy?
- Calidi Biotherapeutics share price is 2.14 while CLDI 8-day simple moving average is 2.36, which is a Sell signal.
- The stock price of CLDI is 2.14 while Calidi Biotherapeutics 20-day SMA is 1.80, which makes it a Buy.
- Calidi Biotherapeutics 50-day simple moving average is 1.38 while CLDI share price is 2.14, making it a Buy technically.
- CLDI stock price is 2.14 and Calidi Biotherapeutics 200-day simple moving average is 2.71, creating a Sell signal.
CLDI Technical Analysis vs Fundamental Analysis
Buy
52
Calidi Biotherapeutics (CLDI)
is a Buy
Is Calidi Biotherapeutics a Buy or a Sell?
-
Calidi Biotherapeutics stock is rated a Buy
The current Calidi Biotherapeutics [CLDI] share price is $2.14. The Score for CLDI is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
Calidi Biotherapeutics Stock Info
Market Cap:
37.48M
Price in USD:
2.14
Share Volume:
1.47M
Calidi Biotherapeutics 52-Week Range
52-Week High:
26.30
52-Week Low:
0.73
Buy
52
Calidi Biotherapeutics (CLDI)
is a Buy
Calidi Biotherapeutics Share Price Forecast
-
What is the Calidi Biotherapeutics stock price today?
The Calidi Biotherapeutics stock price is 2.14 USD today. -
Will CLDI stock go up or go down?
Calidi Biotherapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Calidi Biotherapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Calidi Biotherapeutics is not overvalued.
Is Calidi Biotherapeutics Stock a Buy?
- Calidi Biotherapeutics share price is 2.14 while CLDI 8-day exponential moving average is 2.18, which is a Sell signal.
- The stock price of CLDI is 2.14 while Calidi Biotherapeutics 20-day EMA is 1.90, which makes it a Buy.
- Calidi Biotherapeutics 50-day exponential moving average is 1.60 while CLDI share price is 2.14, making it a Buy technically.
- CLDI stock price is 2.14 and Calidi Biotherapeutics 200-day simple moving average is 8.19, creating a Sell signal.
Fundamental Analysis of Calidi Biotherapeutics
Is Calidi Biotherapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.72 per share, and an increase next year of $0.29 per share.
Technical Analysis of Calidi Biotherapeutics
Should I short Calidi Biotherapeutics stock?
- CLDI Moving Average Covergence Divergence (MACD) indicator is 0.29, suggesting Calidi Biotherapeutics is a Buy
- Calidi Biotherapeutics Relative Strength Index (RSI) is 56.69, which suggest Calidi Biotherapeutics is overbought
- The Bollinger Bands (25) for Calidi Biotherapeutics is (1.04 - 2.24), which suggest Calidi Biotherapeutics is a Buy
- The Bollinger Bands (100) for Calidi Biotherapeutics is (1.03 - 1.83), which suggest Calidi Biotherapeutics is a Buy
* Calidi Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.